191 related articles for article (PubMed ID: 28776678)
1. Development of postcompressional textural tests to evaluate the mechanical properties of medicated chewing gum tablets with high drug loadings.
Al Hagbani T; Nazzal S
J Texture Stud; 2018 Feb; 49(1):30-37. PubMed ID: 28776678
[TBL] [Abstract][Full Text] [Related]
2. A full factorial experimental design to study the effect of flavoring agents on the mechanical properties of curcumin chewing gum tablets with high solids content.
Al Hagbani T; Kamal MM; Nazzal S
Drug Dev Ind Pharm; 2020 Apr; 46(4):539-546. PubMed ID: 32090628
[No Abstract] [Full Text] [Related]
3. Mechanical Characterization and Dissolution of Chewing Gum Tablets (CGTs) Containing Co-compressed Health in Gum® and Curcumin/Cyclodextrin Inclusion Complex.
Al Hagbani T; Altomare C; Kamal MM; Nazzal S
AAPS PharmSciTech; 2018 Nov; 19(8):3742-3750. PubMed ID: 30255470
[TBL] [Abstract][Full Text] [Related]
4. D-optimal mixture design: Formulation development, mechanical characterization, and optimization of curcumin chewing gums using oppanol® B 12 elastomer as a gum-base.
Al Hagbani T; Altomare C; Salawi A; Nazzal S
Int J Pharm; 2018 Dec; 553(1-2):210-219. PubMed ID: 30347275
[TBL] [Abstract][Full Text] [Related]
5. Medicated Chewing Gums (MCGs): Composition, Production, and Mechanical Testing.
Al Hagbani T; Nazzal S
AAPS PharmSciTech; 2018 Oct; 19(7):2908-2920. PubMed ID: 30088152
[TBL] [Abstract][Full Text] [Related]
6. Formulation development of medicated chewing gum tablets by direct compression using the SeDeM-Diagram-Expert-System.
Zieschang L; Klein M; Jung N; Krämer J; Windbergs M
Eur J Pharm Biopharm; 2019 Nov; 144():68-78. PubMed ID: 31493511
[TBL] [Abstract][Full Text] [Related]
7. Study of the compressibility of chewing gum and its applicability as an oral drug delivery system.
Jójárt I; Kása P; Kelemen A; Pintye-Hódi K
Pharm Dev Technol; 2016; 21(3):321-7. PubMed ID: 25673279
[TBL] [Abstract][Full Text] [Related]
8. Development of medicated chewing gum of taste masked levocetirizine dihydrochloride using different gum bases:
Marzouk MA; Darwish MK; Abd El-Fattah MA
Drug Dev Ind Pharm; 2020 Mar; 46(3):395-402. PubMed ID: 31996053
[No Abstract] [Full Text] [Related]
9. Chewability testing in the development of a chewable tablet for hyperphosphatemia.
Lanz M; Baldischweiler J; Kriwet B; Schill J; Stafford J; Imanidis G
Drug Dev Ind Pharm; 2014 Dec; 40(12):1623-31. PubMed ID: 24010939
[TBL] [Abstract][Full Text] [Related]
10. Impact of Compression Force on Mechanical, Textural, Release and Chewing Perception Properties of Compressible Medicated Chewing Gums.
Maslii Y; Kolisnyk T; Ruban O; Yevtifieieva O; Gureyeva S; Goy A; Kasparaviciene G; Kalveniene Z; Bernatoniene J
Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834223
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of release characteristics of 3TabGum, a novel chewing device.
Maggi L; Segale L; Conti S; Ochoa Machiste E; Salini A; Conte U
Eur J Pharm Sci; 2005 Apr; 24(5):487-93. PubMed ID: 15784338
[TBL] [Abstract][Full Text] [Related]
12. Formulation study of directly compressible chewable polymers containing ascorbic acid.
Kása P; Jójárt I; Kelemen A; Pintye-Hódi K
Pharm Dev Technol; 2013; 18(2):384-9. PubMed ID: 22229257
[TBL] [Abstract][Full Text] [Related]
13. Confectionery Xylitol Gum-Containing Tablets for Medical Application and the Sintering Effect on Gum Tablets.
Tagami T; Kuwata E; Ozeki T
Biol Pharm Bull; 2021; 44(9):1309-1315. PubMed ID: 34471059
[TBL] [Abstract][Full Text] [Related]
14. Medicated Chewing Gums: Recent Patents and Patented Technology Platforms.
Kaushik P; Kaushik D
Recent Pat Drug Deliv Formul; 2019; 13(3):184-191. PubMed ID: 31960787
[TBL] [Abstract][Full Text] [Related]
15. The relative bioavailability of loratadine administered as a chewing gum formulation in healthy volunteers.
Noehr-Jensen L; Damkier P; Bidstrup TB; Pedersen RS; Nielsen F; Brosen K
Eur J Clin Pharmacol; 2006 Jun; 62(6):437-45. PubMed ID: 16770647
[TBL] [Abstract][Full Text] [Related]
16. Use of dye as tracer of drug release from medicated chewing gums.
Ochoa E; Maggi L; Conti S; Conte U; Vergnault G; Grenier P
Eur J Pharm Biopharm; 2008 Mar; 68(3):811-7. PubMed ID: 17951037
[TBL] [Abstract][Full Text] [Related]
17. A randomised, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation.
Seibel K; Schaffler K; Reitmeir P; Golly I
Arzneimittelforschung; 2002; 52(7):529-36. PubMed ID: 12189776
[TBL] [Abstract][Full Text] [Related]
18. Medicated chewing gum, a novel drug delivery system.
Aslani A; Rostami F
J Res Med Sci; 2015 Apr; 20(4):403-11. PubMed ID: 26109999
[TBL] [Abstract][Full Text] [Related]
19. Development of a Chewing Robot With Built-in Humanoid Jaws to Simulate Mastication to Quantify Robotic Agents Release From Chewing Gums Compared to Human Participants.
Alemzadeh K; Jones SB; Davies M; West N
IEEE Trans Biomed Eng; 2021 Feb; 68(2):492-504. PubMed ID: 32746044
[TBL] [Abstract][Full Text] [Related]
20. An index for evaluating difficulty of Chewing Index for chewable tablets.
Gupta A; Chidambaram N; Khan MA
Drug Dev Ind Pharm; 2015 Feb; 41(2):239-43. PubMed ID: 24252107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
